Article Versions Notes

Mohamed AS, Awwad AR, Chacko AA, Dey S, Braithwaite B, Bhuju R, Elias S. Adrenal Insufficiency Induced by Continued Abiraterone Acetate Use in a Prostate Cancer Patient in Remission: The Dangers of Unmonitored Long-Term Therapy Without Corticosteroids. Current Oncology. 2025; 32(3):156. https://doi.org/10.3390/curroncol32030156

Mohamed, Ahmed S., Ahmad R. Awwad, Angel Ann Chacko, Shraboni Dey, Brianna Braithwaite, Ruchi Bhuju, and Sameh Elias. 2025. "Adrenal Insufficiency Induced by Continued Abiraterone Acetate Use in a Prostate Cancer Patient in Remission: The Dangers of Unmonitored Long-Term Therapy Without Corticosteroids" Current Oncology 32, no. 3: 156. https://doi.org/10.3390/curroncol32030156

Mohamed, A. S., Awwad, A. R., Chacko, A. A., Dey, S., Braithwaite, B., Bhuju, R., & Elias, S. (2025). Adrenal Insufficiency Induced by Continued Abiraterone Acetate Use in a Prostate Cancer Patient in Remission: The Dangers of Unmonitored Long-Term Therapy Without Corticosteroids. Current Oncology, 32(3), 156. https://doi.org/10.3390/curroncol32030156